Cafepharma Today

May 16 2025 - Novo CEO to depart as obesity drugmaker’s challenges rise
Novo CEO to depart as obesity drugmaker’s challenges rise
BioMarin expands enzyme expertise with $270M Inozyme buy
Amgen could owe Regeneron more than $400M after defeat in cholesterol drug antitrust suit
Eli Lilly collaborates with Rznomics on hearing loss treatment in $1.3 billion pact
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Pfizer Acts on Growing Interest in Niche Drugs
Seeking Alpha
Friday, September 3, 2010 - 8:06am
tags:
Protalix BioTherapeutics, Pfizer, UPLYSO, M&A, tafamidis meglumine, FoldRx
Does Amgen Pass Buffett's Test?
Motley Fool
Friday, September 3, 2010 - 8:03am
tags:
Warren Buffett, Amgen
The 7 Most Popular High Yielders in Pharma
Motley Fool
Thursday, September 2, 2010 - 8:50pm
tags:
Pfizer, JNJ, Merck, Abbott Laboratories, Bristol-Myers Squibb, GSK, Novartis
HR Hell at Pfizer: Retiree’s Stock Options Are Cancelled in a Paperwork Error
BNET Pharma
Thursday, September 2, 2010 - 6:22pm
tags:
Pfizer, stock options
Strong Data for Transdel Pharma
Yahoo/Zacks.com
Thursday, September 2, 2010 - 6:20pm
tags:
Transdel
Two Undervalued China Pharma Stocks
TheStreet.com
Thursday, September 2, 2010 - 6:16pm
tags:
China, Skystar Bio-Pharmaceutical, China Sky One Medical
Otsuka Said to Hire Morgan Stanley, Nomura, UBS to Manage Drugmaker's IPO
Bloomberg
Thursday, September 2, 2010 - 4:21pm
tags:
Japan, Otsuka, IPOs
Volume Hunter: Diet Stocks Lift Biotech
Yahoo/IndieResearch
Thursday, September 2, 2010 - 4:01pm
tags:
diet drugs, biotech, Arena Pharmaceuticals, Dendreon, Provenge, Exelixis, Vivus, Orexigen, Takeda, Contrave, Martek
American Heart Association, Avandia & Ghostwriting
Pharmalot
Thursday, September 2, 2010 - 3:58pm
tags:
Avandia, GSK, diabetes, Ghostwriting
Forest Faces a Positive-Leaning Panel
Minyanville
Thursday, September 2, 2010 - 3:57pm
tags:
Forest Labs, FDA, advisory panels, antibiotics, ceftaroline
Dendreon Shares Up on Provenge Medicare Coverage Meeting Scheduling
WSJ Online
Thursday, September 2, 2010 - 10:02am
tags:
Dendreon, Provenge, prostate cancer, Medicare
Martek grows profit by 33 percent in 3Q
Bizjournals.com
Thursday, September 2, 2010 - 10:01am
tags:
Martek, earnings
Don't Let It Happen, Celgene
Motley Fool
Thursday, September 2, 2010 - 9:44am
tags:
Celgene
[video] Pfizer and Merck To Make Acquisitions
TheStreet.com
Thursday, September 2, 2010 - 9:42am
tags:
M&A, Pfizer, Merck, Genzyme, Sanofi
Does Pfizer Pass Buffett's Test?
Motley Fool
Thursday, September 2, 2010 - 9:41am
tags:
Warren Buffett, Pfizer
The 15 Highest-Yielding Pharma & Biotech Stocks
Motley Fool
Thursday, September 2, 2010 - 9:24am
tags:
PDL Biopharma, Eli Lilly, Sanofi, GSK, Bristol-Myers Squibb, AstraZeneca, Pfizer, Merck, Novartis, JNJ, Abbott Laboratories, Pharmaceutical Product Development, Techne, Biovail, Novo Nordisk
Europe says yes to AstraZeneca’s Seroquel XR
Pharma Times, UK
Thursday, September 2, 2010 - 9:17am
tags:
Europe, AstraZeneca, Seroquel XR, antipsychotics
Why Anavex Is a Strong Buy
Seeking Alpha
Thursday, September 2, 2010 - 9:14am
tags:
Anavex, semagacestat, Eli Lilly, Alzheimer's disease
Orexigen, Takeda Tie Knot on Obesity Drug
TheStreet.com
Thursday, September 2, 2010 - 8:18am
tags:
Orexigen, Takeda, obesity, Contrave, partnerships
FDA Warns On Increased Death Risk With Pfizer Antibiotic
NASDAQ.com
Thursday, September 2, 2010 - 8:17am
tags:
FDA, Pfizer, Tygacil, antibiotics, warnings

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.